市场调查报告书

蛋白质体学的全球市场:2025年前的各用途,各适应症,各技术,各类型、 各产品,各终端用户,各地区的竞争,预测,机会

Global Proteomics Market By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 934758
出版日期 内容资讯 英文 115 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

蛋白质体学的全球市场:2025年前的各用途,各适应症,各技术,各类型、 各产品,各终端用户,各地区的竞争,预测,机会 Global Proteomics Market By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日内容资讯: 英文 115 Pages
简介

本报告提供全球蛋白质体学市场调查,提供各地区市场展望,市场力学,主要的趋势,竞争情形等资讯,并提供策略性建议。

目录

第1章 产品概要

第2章 调查手法

第3章 摘要整理

第4章 全球蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途(药物研发,诊断生物标志物的发现,临床诊断,其他)
    • 各适应症(感染疾病,循环系统,神经血管,糖尿病,其他)
    • 各技术
    • 各类型(功能,表现,结构,计算)
    • 各产品(软体,设备,试剂及化验,服务)
    • 各终端用户(制药及生物科技企业、 调查机关,CRO)
    • 各公司(2019)
    • 各地区
  • 市场魅力指数

第5章 亚太地区的蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途
    • 各适应症
    • 各技术
    • 各类型
    • 各产品
    • 各终端用户
    • 各国
  • 市场魅力指数
  • 亚太地区:国家分析
    • 中国蛋白质体学市场展望
    • 印度的蛋白质体学市场展望
    • 日本的蛋白质体学市场展望
    • 韩国的蛋白质体学市场展望
    • 新加坡的蛋白质体学市场展望
    • 澳洲的蛋白质体学市场展望

第6章 欧洲的蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途
    • 各适应症
    • 各技术
    • 各类型
    • 各产品
    • 各终端用户
    • 各国
  • 市场魅力指数
  • 欧洲:国家分析
    • 法国的蛋白质体学市场展望
    • 德国的蛋白质体学市场展望
    • 英国的蛋白质体学市场展望
    • 义大利的蛋白质体学市场展望

第7章 北美的蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途
    • 各适应症
    • 各技术
    • 各类型
    • 各产品
    • 各终端用户
    • 各国
  • 市场魅力指数
  • 北美:国家分析
    • 美国蛋白质体学市场展望
    • 墨西哥的蛋白质体学市场展望
    • 加拿大的蛋白质体学市场展望

第8章 南美的蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途
    • 各适应症
    • 各技术
    • 各类型
    • 各产品
    • 各终端用户
    • 各国
  • 市场魅力指数
  • 南美:国家分析
    • 巴西的蛋白质体学市场展望
    • 阿根廷的蛋白质体学市场展望
    • 哥伦比亚的蛋白质体学市场展望

第9章 中东和非洲的蛋白质体学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 各用途
    • 各适应症
    • 各技术
    • 各类型
    • 各产品
    • 各终端用户
    • 各国
  • 市场魅力指数
  • 中东·非洲地区:国家分析
    • 南非的蛋白质体学市场展望
    • 沙乌地阿拉伯蛋白质体学市场展望
    • UAE蛋白质体学市场展望

第10章 市场动态

  • 促进因素
  • 课题

第11章 市场趋势

第12章 竞争情形

  • 竞争的展望
  • 主要企业的简介
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Waters Corporation
    • Bio-Rad Laboratories
    • GE Healthcare
    • PerkinElmer
    • Creative Proteomics
    • Luminex Corporation
    • Promega Corporation
    • Caprion
    • Bruker
    • Pfizer
    • Horiba
    • Qiagen
    • Becton Dickinson
    • Bioproximity
    • Biocon
    • Evotec
    • Bristol-Myers Squibb
    • Illumina
    • Takeda Pharmaceuticals

第13章 策略性建议

第14章 免责声明

目录
Product Code: 4559

Global proteomics market is expected to grow at a brisk CAGR during the forecast period. The key factor responsible for increased demand for proteomics is due to growing investments in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2025.

The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into drug discovery, diagnostic biomarker discovery, clinical diagnostic, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem MS and LC are some proteomics technology that are effective for the identification of proteins, thus boosting the growth of the segment across the globe.

Major players operating in the global proteomics market include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, GE Healthcare, PerkinElmer, Creative Proteomics, Luminex Corporation, Promega Corporation, Caprion, Bruker, Pfizer, Horiba, Qiagen, Becton Dickinson, Bioproximity, Biocon, Evotec, Bristol-Myers Squibb, Illumina, Takeda Pharmaceuticals, etc. The companies operating in proteomics market across the globe are focussing more towards the expanding their share in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global proteomics market.
  • To classify and forecast global proteomics market based on application, indication, technology, type, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global proteomics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global proteomics market.
  • To conduct pricing analysis for global proteomics market.
  • To identify and analyse the profile of leading players operating in global proteomics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Proteomics companies, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to proteomics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Application:

Drug Discovery

Diagnostic Biomarker Discovery

Clinical diagnostic

Others

  • Market, By Indication:

Infectious Disease

Cardiology

Neurovascular

Diabetes

Others

  • Market, By Technology:

Conventional

  • Chromatography
  • ELISA
  • Western blotting

Advanced

  • Protein microarray
  • Gel electrophoresis
  • Mass Spectrophotometry
  • Edman Sequencing

Quantitative

  • Isotope-coded affinity tag labelling
  • Stable isotope labelling with amino acids in cell culture
  • Isobaric tag for relative and absolute quantitation

High-thoroughput

  • X-ray crystallography
  • NMR

Bioinformatic analysis

  • Market, By Type:

Functional

Expression

Structural

Computational

  • Market, By Product:

Software

Instruments

Reagents and Assays

Services

  • Market, By End-User:

Pharmaceutical and biotechnology companies

Research institutes

CROs

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global proteomics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Proteomics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application (Drug Discovery, Diagnostic Biomarker Discovery, Clinical diagnostic, Others)
    • 4.2.2. By Indication (Infectious Disease, Cardiology, Neurovascular, Diabetes, Others)
    • 4.2.3. By Technology
        • 4.2.3.1.1. Conventional (Chromatography (HPLC, Affinity, Others), ELISA, Western blotting)
        • 4.2.3.1.2. Advanced (Protein microarray (Analytical, Functional, Reverse-phase), Gel electrophoresis (2D, Capillary, SDS-PAGE, 2D-DIGE), Mass Spectrophotometry, Edman Sequencing)
        • 4.2.3.1.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
        • 4.2.3.1.4. High-thoroughput (X-ray crystallography, NMR)
        • 4.2.3.1.5. Bioinformatic analysis
    • 4.2.4. By Type (Functional, Expression, Structural, Computational)
    • 4.2.5. By Product (Software, Instruments, Reagents and Assays, Services)
    • 4.2.6. By End-User (Pharmaceutical and biotechnology companies, Research institutes, CROs)
    • 4.2.7. By Company (2019)
    • 4.2.8. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Proteomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application
    • 5.2.2. By Indication
    • 5.2.3. By Technology
    • 5.2.4. By Type
    • 5.2.5. By Product
    • 5.2.6. By End-User
    • 5.2.7. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Proteomics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Application
        • 5.4.1.2.2. By Indication
        • 5.4.1.2.3. By Technology
        • 5.4.1.2.4. By Type
        • 5.4.1.2.5. By Product
        • 5.4.1.2.6. By End-User
    • 5.4.2. India Proteomics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Application
        • 5.4.2.2.2. By Indication
        • 5.4.2.2.3. By Technology
        • 5.4.2.2.4. By Type
        • 5.4.2.2.5. By Product
        • 5.4.2.2.6. By End-User
    • 5.4.3. Japan Proteomics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Application
        • 5.4.3.2.2. By Indication
        • 5.4.3.2.3. By Technology
        • 5.4.3.2.4. By Type
        • 5.4.3.2.5. By Product
        • 5.4.3.2.6. By End-User
    • 5.4.4. South Korea Proteomics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Application
        • 5.4.4.2.2. By Indication
        • 5.4.4.2.3. By Technology
        • 5.4.4.2.4. By Type
        • 5.4.4.2.5. By Product
        • 5.4.4.2.6. By End-User
    • 5.4.5. Singapore Proteomics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Application
        • 5.4.5.2.2. By Indication
        • 5.4.5.2.3. By Technology
        • 5.4.5.2.4. By Type
        • 5.4.5.2.5. By Product
        • 5.4.5.2.6. By End-User
    • 5.4.6. Australia Proteomics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Application
        • 5.4.6.2.2. By Indication
        • 5.4.6.2.3. By Technology
        • 5.4.6.2.4. By Type
        • 5.4.6.2.5. By Product
        • 5.4.6.2.6. By End-User

6. Europe Proteomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Indication
    • 6.2.3. By Technology
    • 6.2.4. By Type
    • 6.2.5. By Product
    • 6.2.6. By End-User
    • 6.2.7. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Proteomics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Application
        • 6.4.1.2.2. By Indication
        • 6.4.1.2.3. By Technology
        • 6.4.1.2.4. By Type
        • 6.4.1.2.5. By Product
        • 6.4.1.2.6. By End-User
    • 6.4.2. Germany Proteomics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Application
        • 6.4.2.2.2. By Indication
        • 6.4.2.2.3. By Technology
        • 6.4.2.2.4. By Type
        • 6.4.2.2.5. By Product
        • 6.4.2.2.6. By End-User
    • 6.4.3. United Kingdom Proteomics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Application
        • 6.4.3.2.2. By Indication
        • 6.4.3.2.3. By Technology
        • 6.4.3.2.4. By Type
        • 6.4.3.2.5. By Product
        • 6.4.3.2.6. By End-User
    • 6.4.4. Italy Proteomics Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Application
        • 6.4.4.2.2. By Indication
        • 6.4.4.2.3. By Technology
        • 6.4.4.2.4. By Type
        • 6.4.4.2.5. By Product
        • 6.4.4.2.6. By End-User

7. North America Proteomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Indication
    • 7.2.3. By Technology
    • 7.2.4. By Type
    • 7.2.5. By Product
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Proteomics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Application
        • 7.4.1.2.2. By Indication
        • 7.4.1.2.3. By Technology
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Product
        • 7.4.1.2.6. By End-User
    • 7.4.2. Mexico Proteomics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Application
        • 7.4.2.2.2. By Indication
        • 7.4.2.2.3. By Technology
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Product
        • 7.4.2.2.6. By End-User
    • 7.4.3. Canada Proteomics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Application
        • 7.4.3.2.2. By Indication
        • 7.4.3.2.3. By Technology
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Product
        • 7.4.3.2.6. By End-User

8. South America Proteomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Indication
    • 8.2.3. By Technology
    • 8.2.4. By Type
    • 8.2.5. By Product
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Proteomics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Application
        • 8.4.1.2.2. By Indication
        • 8.4.1.2.3. By Technology
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Product
        • 8.4.1.2.6. By End-User
    • 8.4.2. Argentina Proteomics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Application
        • 8.4.2.2.2. By Indication
        • 8.4.2.2.3. By Technology
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Product
        • 8.4.2.2.6. By End-User
    • 8.4.3. Colombia Proteomics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Application
        • 8.4.3.2.2. By Indication
        • 8.4.3.2.3. By Technology
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Product
        • 8.4.3.2.6. By End-User

9. Middle East and Africa Proteomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Indication
    • 9.2.3. By Technology
    • 9.2.4. By Type
    • 9.2.5. By Product
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Proteomics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Application
        • 9.4.1.2.2. By Indication
        • 9.4.1.2.3. By Technology
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Product
        • 9.4.1.2.6. By End-User
    • 9.4.2. Saudi Arabia Proteomics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Application
        • 9.4.2.2.2. By Indication
        • 9.4.2.2.3. By Technology
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Product
        • 9.4.2.2.6. By End-User
    • 9.4.3. UAE Proteomics Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Application
        • 9.4.3.2.2. By Indication
        • 9.4.3.2.3. By Technology
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Product
        • 9.4.3.2.6. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Thermo Fisher Scientific
    • 12.2.2. Agilent Technologies
    • 12.2.3. Waters Corporation
    • 12.2.4. Bio-Rad Laboratories
    • 12.2.5. GE Healthcare
    • 12.2.6. PerkinElmer
    • 12.2.7. Creative Proteomics
    • 12.2.8. Luminex Corporation
    • 12.2.9. Promega Corporation
    • 12.2.10. Caprion
    • 12.2.11. Bruker
    • 12.2.12. Pfizer
    • 12.2.13. Horiba
    • 12.2.14. Qiagen
    • 12.2.15. Becton Dickinson
    • 12.2.16. Bioproximity
    • 12.2.17. Biocon
    • 12.2.18. Evotec
    • 12.2.19. Bristol-Myers Squibb
    • 12.2.20. Illumina
    • 12.2.21. Takeda Pharmaceuticals

13. Strategic Recommendations

14. About Us & Disclaimer